Evidence map›Paper›PMID 41331258›Full record

ArticleNature communications2025

Major waves of H2A.Z incorporation during mouse oogenesis and preimplantation embryo development.

Madeleine Fosslie, Erkut Ilaslan, Trine Skuland, Michel Choudalakis, Mirra Søegaard, Jason Alexander Halliwell, Shaista Khan, Marie Indahl, Maria Vera-Rodriguez, Adeel Manaf and 13 more

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Madeleine Fosslie *Department of Microbiology, Oslo University Hospital, 0372, Oslo, Norway.ORCID 0000-0002-2902-4394
Erkut Ilaslan *CRESCO, Centre for Embryology and Healthy Development, University of Oslo, 0373, Oslo, Norway.ORCID 0000-0002-1024-7491
Trine SkulandDepartment of Reproductive Medicine, Oslo University Hospital, 0855, Oslo, Norway.ORCID 0000-0001-9618-5123
Michel ChoudalakisDepartment of Microbiology, Oslo University Hospital, 0372, Oslo, Norway.ORCID 0000-0002-8778-3380
Mirra SøegaardDepartment of Microbiology, Oslo University Hospital, 0372, Oslo, Norway.
Jason Alexander HalliwellDNRF Center for Chromosome Stability, Department of Cellular and Molecular Medicine, University of Copenhagen, DK-2200 Copenhagen, Denmark University of Copenhagen, DK-2200, Copenhagen, Denmark.ORCID 0000-0003-1070-1866
Shaista KhanNorwegian Transgenic Center (NTS), University of Oslo, 0373, Oslo, Norway.
Marie IndahlDepartment of Microbiology, Oslo University Hospital, 0372, Oslo, Norway.
Maria Vera-RodriguezCRESCO, Centre for Embryology and Healthy Development, University of Oslo, 0373, Oslo, Norway.ORCID 0000-0002-4879-241X
Adeel ManafDepartment of Microbiology, Oslo University Hospital, 0372, Oslo, Norway.ORCID 0000-0002-9958-8654
Annika Vera Geijer-SimpsonCRESCO, Centre for Embryology and Healthy Development, Department of Biotechnology, University of Inland Norway, Hamar, Norway.
Rajikala SuganthanDepartment of Microbiology, Oslo University Hospital, 0372, Oslo, Norway.
Ingunn JermstadNorwegian Transgenic Center (NTS), University of Oslo, 0373, Oslo, Norway.
Knut Tomas DalenNorwegian Transgenic Center (NTS), University of Oslo, 0373, Oslo, Norway.ORCID 0000-0002-0270-5982
Ragnhild EskelandDepartment of Molecular Medicine, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway.ORCID 0000-0003-2789-3171
Elisabeth KommisrudCRESCO, Centre for Embryology and Healthy Development, Department of Biotechnology, University of Inland Norway, Hamar, Norway.ORCID 0000-0001-5867-4815
Arne KlunglandDepartment of Microbiology, Oslo University Hospital, 0372, Oslo, Norway.ORCID 0000-0001-7274-3661
Magnar BjøråsDepartment of Microbiology, Oslo University Hospital, 0372, Oslo, Norway.ORCID 0000-0001-8759-1170
Peter FedorcsakCRESCO, Centre for Embryology and Healthy Development, University of Oslo, 0373, Oslo, Norway.
Gareth D GreggainsDepartment of Microbiology, Oslo University Hospital, 0372, Oslo, Norway.
Mika ZagrobelnyCRESCO, Centre for Embryology and Healthy Development, University of Oslo, 0373, Oslo, Norway. mikaza@sund.ku.dk.ORCID 0000-0001-5574-2894
John Arne DahlDepartment of Microbiology, Oslo University Hospital, 0372, Oslo, Norway. j.a.dahl@medisin.uio.no.ORCID 0000-0002-4375-2697
Mads LerdrupCRESCO, Centre for Embryology and Healthy Development, University of Oslo, 0373, Oslo, Norway. mlerdrup@sund.ku.dk.ORCID 0000-0002-7730-8973

Funding

Carlsbergfondet (Carlsberg Foundation) CF22-1209 & CF21-0571Danmarks Grundforskningsfond (Danish National Research Foundation) DNRF115Novo Nordisk Fonden (Novo Nordisk Foundation) NNF22OC0080710 & NNF22OC0074308
6 · The paper itself

Abstract

Epigenomes of mammalian oocytes and embryos undergo major transitions essential for successful development. Here, we provide genome-wide maps of histone variant H2A.Z during twelve stages of mouse oogenesis and preimplantation embryo development and relate it to histone marks and genomic features. This revealed that major waves of H2A.Z incorporation occur early in growing oocytes, forming distinct patterns of maternal, embryonic, and persistent H2A.Z enrichment. Late maternal enrichment is inherited by the zygote and precedes reduced formation of lamina associated domains and early replication in the maternal genome of 2-cell embryos. Persistent H2A.Z enrichment is strongly associated with CpG islands and H3K4me3 near transcription start sites of active genes, but thousands of maternal and embryonic H2A.Z incorporation sites exist elsewhere, frequently at transposable elements. The persisting H2A.Z enrichments across related developmental stages enable preservation of epigenetic information despite major concurrent changes in H3K4me3, H3K27me3, and DNA methylation. Altogether, this advances our understanding of how histone variants contribute to epigenetic reprogramming during mammalian oogenesis and early development.

Indexed as

BlastocystEmbryonic DevelopmentHistonesOogenesisAnimalsCpG IslandsDNA MethylationEpigenesis, GeneticFemaleGene Expression Regulation, DevelopmentalMiceOocytesZygotehistone H2A.F-Zhistone H3 trimethyl Lys4Histones

Identifiers

PMID41331258
PMCPMC12779981

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.